An Orally Efficacious Thyrotropin Receptor Ligand Inhibits Growth and Metastatic Activity of Thyroid Cancers

Rhitajit Sarkar(National Institutes of Health), Marvin C. Gershengorn(National Institutes of Health)
The Journal of Clinical Endocrinology & Metabolism
February 27, 2024
Cited by 9


Related Papers